GGrantIndex
Sort

27,075 grants matching cholesterol

SPORE in Pancreatic Cancer

$2,162,000
Michael A Hollingsworth · University Of Nebraska Medical Center · P50 · FY2016 · CA

SPORE in Pancreatic Cancer

$2,162,000
Michael A Hollingsworth · University Of Nebraska Medical Center · P50 · FY2014 · CA

Basic and Translational Studies of Inborn Errors of Metabolism

$2,152,087
Forbes Porter · Eunice Kennedy Shriver National Institute Of Child Health & Human Development · ZIA · FY2022 · HD

MOLECULAR GENETIC APPROCHES IN ATHEROSCLEROSIS RESEARCH

$2,149,635
University Of California Los Angeles · P01 · FY2001 · HL

EXPLOITING DYSREGULATION OF CHOLESTEROL HOMEOSTASIS AS A NOVEL THERAPY FOR PROSTATE CANCER

$2,148,861
Cedars-Sinai Medical Center · · FY2017 · Department of the Army

ACCORD

$2,148,794
Robert P Byington · Wake Forest University Health Sciences · N01 · FY2010 · HL

Imaging Pathophysiology in Aging and Neurodegeneration

$2,148,033
Ann D. Cohen · University Of Pittsburgh At Pittsburgh · P01 · FY2020 · AG

Role of O-glycosylation in Animal Development

$2,147,446
Kelly G Ten Hagen · National Institute Of Dental & Craniofacial Research · ZIA · FY2024 · DE

Vaccine and immunotherapy strategies for cancer and viruses causing cancer

$2,147,209
Jay A Berzofsky · Division Of Clinical Sciences - Nci · ZIA · FY2023 · CA

Studies of the SARS-CoV-2 Spike Protein

$2,147,209
Jay A Berzofsky · Division Of Basic Sciences - Nci · ZIA · FY2023 · CA

AAV Gene Therapy for Lipid Disorders

$2,139,766
James M Wilson · University Of Pennsylvania · P01 · FY2018 · HL

Regulation of CHCHD6 in Alzheimer's disease

$2,136,033
Xin Qi · Case Western Reserve University · RF1 · FY2022 · AG

New York Columbia Collaborative SPOTRIAS

$2,135,332
Randolph S Marshall · Columbia University Health Sciences · P50 · FY2013 · NS

Leveraging multi-omics approaches to examine metabolic challenges of obesity in relation to cardiovascular diseases

$2,131,573
Penny Gordon-Larsen · Univ Of North Carolina Chapel Hill · R01 · FY2022 · HL

Mechanisms of Atherogenesis in Insulin Resistance

$2,130,062
Ira A Tabas · Columbia University Health Sciences · P01 · FY2022 · HL

Mechanisms of Atherogenesis in Insulin Resistance

$2,130,062
Ira A Tabas · Columbia University Health Sciences · P01 · FY2021 · HL

Mechanisms of Atherogenesis in Insulin Resistance

$2,130,062
Ira A Tabas · Columbia University Health Sciences · P01 · FY2020 · HL

Mechanisms of Atherogenesis in Insulin Resistance

$2,130,062
Ira A Tabas · Columbia University Health Sciences · P01 · FY2019 · HL

Molecular Analysis Of Human Natural Killer Cells

$2,127,153
Eric O Long · National Institute Of Allergy And Infectious Diseases · Z01 · FY2008 · AI

Alzheimer Disease Research Center

$2,126,939
Helena Chang Chui · University Of Southern California · P50 · FY2019 · AG

SCOR in Molecular Medicine and Atherosclerosis

$2,126,786
University Of California San Diego · P50 · FY2005 · HL

DASH-Sodium Trial in Adolescents

$2,125,874
Connie M Weaver · Purdue University · U01 · FY2016 · HL

Neuronal Protective Apolipoprotein E2-mediated endocytic and exocytic pathways

$2,124,773
Efrat Levy · New York University School Of Medicine · RF1 · FY2017 · AG

Coronary Artery Calcium and its Association with Protective/Risk Factors and Epigenetic Patterns in Diverse US Hispanic/Latino Adults

$2,124,498
Martha L Daviglus · University Of Illinois At Chicago · R01 · FY2021 · HL

Center for Health Promotion and Disease Prevention

$2,121,727
Alice S. Ammerman · Univ Of North Carolina Chapel Hill · U48 · FY2018 · DP